Document is current
Any future updates will be listed below
-
Authors
Ramesh, Siddhi
Dyer, Emma
Pomaville, Monica https://orcid.org/0009-0008-0498-5544
Doytcheva, Kristina
Dolezal, James https://orcid.org/0000-0002-6788-7203
Kochanny, Sara
Terhaar, Rachel
Mehrhoff, Casey J.
Patel, Kritika https://orcid.org/0009-0007-3569-294X
Brewer, Jacob
Kusswurm, Benjamin
Naranjo, Arlene
Shimada, Hiroyuki
Cipriani, Nicole A.
Husain, Aliya N.
Pytel, Peter
Sokol, Elizabeth A. https://orcid.org/0000-0002-1787-6901
Cohn, Susan L. https://orcid.org/0000-0001-5749-7650
George, Rani E.
Pearson, Alexander T. https://orcid.org/0000-0003-2801-7456
Applebaum, Mark A.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (P30CA014599)
Burroughs Wellcome Fund Early Scientific Training Program to Prepare for Research Excellence Post-Graduation
- License Information
-
More Information
Article History
Received: 9 May 2024
Accepted: 25 October 2024
First Online: 8 November 2024
Competing interests
: S.R. is the Chief Scientific Officer of Slideflow Labs. J.D. is the Chief Executive Officer of Slideflow Labs. B.K. is a current employee of YouTube. J.B. is an employee of Milliman. S.L.C. reports consulting fees from US WorldMeds. A.T.P. reports consulting fees from Prelude Biotherapeutics, LLC, Ayala Pharmaceuticals, Elvar Therapeutics, Abbvie, and Privo, and contracted research with Kura Oncology, Abbvie, and EMD Serono. A.T.P. is on the Scientific Advisory Board of Slideflow Labs. All other authors report no competing interests.
